All data are based on the daily closing price as of February 7, 2025
c

CJ Bioscience

311690.KQ
6.81 USD
-0.04
-0.58%

Overview

Last close
6.81 usd
Market cap
89.00M usd
52 week high
13.34 usd
52 week low
6.21 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
23.6174
Price/Book Value
2.699
Enterprise Value
66.55M usd
EV/Revenue
24.2066
EV/EBITDA
-6.5568

Key financials

Revenue TTM
3.75M usd
Gross Profit TTM
1.12M usd
EBITDA TTM
-18.99M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
51.05M usd
Net debt
N/A usd

About

CJ Bioscience, Inc. provides microbiome research solutions to companies, hospitals, and individuals in the healthcare field in South Korea and internationally. Its solutions include TrueBac ID, a cloud analysis platform for the identification of microorganism; and EzBioCloud, a public data and analytics portal that offers taxonomy, ecology, genomics, metagenomics, and microbiome of bacteria and archaea. The company also provides Smilegut, a smile intestinal microbial monitoring service; and Smilebaby, a customized healthcare service, which offers information on the growth of infants based on the intestinal microflora. In addition, it offers microbiome taxonomic profiling, whole genome analysis, comparative genome analysis, and bacterial transcriptome analysis services, as well as genome report for industrially important strains. The company was formerly known as ChunLab, Inc. and changed its name to CJ Bioscience, Inc. in December 2021. CJ Bioscience, Inc. was founded in 2009 and is based in Seoul, South Korea.
  • Symbol
    311690.KQ
  • Exchange
    KQ
  • Isin
    N/A
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.cjbioscience.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top